-transparent.png){kind=logo}
Clinical studies on 9,3"-diacetylmidecamycin (MOM) was carried out in 31 patients with respiratory tract infections (acute pharyngitis 6, acute purulent tonsillitis 5, scarlet fever 1, acute bronchitis 6, pneumonia 13 cases), in dose of 12 approximately 34 mg/kg divided 3 per day for 3 approximately 19 days. The overally efficacy rate was 74.2%. As to adverse reaction, exanthema and diarrhea with abdominal pain were observed in each 1 patient. Eosinophilia and elevation of serum GPT were noted in each 1 patient.
Related Publications
R Aoyama, and
Y Kakizaki, and
A Ohnishi, and
Y Izumi, and
M Fujita, and
K Nagata
January 1982,
The Japanese journal of antibiotics,
R Aoyama, and
Y Kakizaki, and
A Ohnishi, and
Y Izumi, and
M Fujita, and
K Nagata
February 1982,
The Japanese journal of antibiotics,
R Aoyama, and
Y Kakizaki, and
A Ohnishi, and
Y Izumi, and
M Fujita, and
K Nagata
February 1982,
The Japanese journal of antibiotics,
R Aoyama, and
Y Kakizaki, and
A Ohnishi, and
Y Izumi, and
M Fujita, and
K Nagata
April 1982,
The Japanese journal of antibiotics,
R Aoyama, and
Y Kakizaki, and
A Ohnishi, and
Y Izumi, and
M Fujita, and
K Nagata
October 1980,
The Japanese journal of antibiotics,
R Aoyama, and
Y Kakizaki, and
A Ohnishi, and
Y Izumi, and
M Fujita, and
K Nagata
March 1982,
The Japanese journal of antibiotics,
R Aoyama, and
Y Kakizaki, and
A Ohnishi, and
Y Izumi, and
M Fujita, and
K Nagata
June 1982,
The Japanese journal of antibiotics,
R Aoyama, and
Y Kakizaki, and
A Ohnishi, and
Y Izumi, and
M Fujita, and
K Nagata
May 1982,
The Japanese journal of antibiotics,
R Aoyama, and
Y Kakizaki, and
A Ohnishi, and
Y Izumi, and
M Fujita, and
K Nagata
January 1982,
The Japanese journal of antibiotics,
R Aoyama, and
Y Kakizaki, and
A Ohnishi, and
Y Izumi, and
M Fujita, and
K Nagata
March 1982,
The Japanese journal of antibiotics,
